TWI369991B - Use of clostridium perfringens type c bacterium for the manufacture of a vaccine - Google Patents
Use of clostridium perfringens type c bacterium for the manufacture of a vaccineInfo
- Publication number
- TWI369991B TWI369991B TW096140460A TW96140460A TWI369991B TW I369991 B TWI369991 B TW I369991B TW 096140460 A TW096140460 A TW 096140460A TW 96140460 A TW96140460 A TW 96140460A TW I369991 B TWI369991 B TW I369991B
- Authority
- TW
- Taiwan
- Prior art keywords
- vaccine
- bacterium
- clostridium perfringens
- manufacture
- perfringens type
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The present invention relates to the use of a vaccine comprising Clostridium perfringens type C bacterium for protecting swine against Clostridium perfringens type A infection.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86044706P | 2006-11-20 | 2006-11-20 | |
EP06124404 | 2006-11-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW200831121A TW200831121A (en) | 2008-08-01 |
TWI369991B true TWI369991B (en) | 2012-08-11 |
Family
ID=38535530
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW096140460A TWI369991B (en) | 2006-11-20 | 2007-10-26 | Use of clostridium perfringens type c bacterium for the manufacture of a vaccine |
Country Status (8)
Country | Link |
---|---|
CN (1) | CN101541343B (en) |
AT (1) | ATE540692T1 (en) |
BR (1) | BRPI0718639A2 (en) |
DK (1) | DK2086578T3 (en) |
ES (1) | ES2380134T3 (en) |
RU (1) | RU2462263C2 (en) |
TW (1) | TWI369991B (en) |
UA (1) | UA95652C2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102688484B (en) * | 2012-06-13 | 2016-03-30 | 北京中海生物科技有限公司 | A kind of production method of chicken necrotizing enterocolitis (C type) inactivated vaccine |
CN107789622A (en) * | 2017-10-18 | 2018-03-13 | 山东农业大学 | A kind of calf enterotoxemia C.perfringens β2The preparation method of toxin toxoid vaccine |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2129441C1 (en) * | 1997-12-10 | 1999-04-27 | Пирожков Михаил Константинович | Mixed vaccine against anaerobic enterotoxemia and escherichiosis in piglets |
UA65816A (en) * | 2003-05-30 | 2004-04-15 | Vasyl Petrovych Ryzhenko | Vaccine velshisan for preventing toxicoinfections caused by clostridium perfringens |
-
2007
- 2007-10-26 TW TW096140460A patent/TWI369991B/en not_active IP Right Cessation
- 2007-11-19 DK DK07822693.3T patent/DK2086578T3/en active
- 2007-11-19 UA UAA200904648A patent/UA95652C2/en unknown
- 2007-11-19 AT AT07822693T patent/ATE540692T1/en active
- 2007-11-19 ES ES07822693T patent/ES2380134T3/en active Active
- 2007-11-19 RU RU2009123478/10A patent/RU2462263C2/en not_active IP Right Cessation
- 2007-11-19 BR BRPI0718639-8A patent/BRPI0718639A2/en not_active Application Discontinuation
- 2007-11-19 CN CN2007800427077A patent/CN101541343B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DK2086578T3 (en) | 2012-05-14 |
CN101541343B (en) | 2012-05-16 |
TW200831121A (en) | 2008-08-01 |
UA95652C2 (en) | 2011-08-25 |
ATE540692T1 (en) | 2012-01-15 |
CN101541343A (en) | 2009-09-23 |
BRPI0718639A2 (en) | 2013-11-26 |
ES2380134T3 (en) | 2012-05-08 |
RU2009123478A (en) | 2010-12-27 |
RU2462263C2 (en) | 2012-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012014082A2 (en) | compositions and methods comprising protease variants | |
MX2012007098A (en) | Phenol derivatives and pharmaceutical or cosmetic use thereof. | |
IN2012DN00829A (en) | ||
MY153915A (en) | Organic compounds | |
MX2012007161A (en) | Phenol derivatives and pharmaceutical or cosmetic use thereof. | |
UA106748C2 (en) | Proline derivatives as cathepsin inhibitors | |
MX2012007507A (en) | Heteroaryl compounds and uses thereof. | |
MX2012004780A (en) | Akt inhibitors. | |
MX2009013354A (en) | Tri-aryl compounds and compositions comprising the same. | |
CA2798214C (en) | Vaccine against beta-herpesvirus infection and use thereof | |
MX2009005938A (en) | 6-oxo.-1, 6-dihydropyrimidin-2-yls in the treatment of proliferative diseases. | |
MX2010004487A (en) | Therapeutic substituted lactams. | |
AU2010280497A8 (en) | Anhydrate of tiotropium bromide | |
UA107592C2 (en) | COMPOSITION FOR CONTROLLING PLANT DISEASES AND ITS APPLICATION | |
MX2009005117A (en) | Use of clostridium perfringens type c bacterium for the manufacture of a vaccine. | |
MX2009001578A (en) | Therapeutic lactams. | |
TWI369991B (en) | Use of clostridium perfringens type c bacterium for the manufacture of a vaccine | |
MX349563B (en) | Pharmaceutical formulation of nanonised fenofibrate. | |
UA96476C2 (en) | Pharmaceutical composition comprising irbesartan | |
MX2009007929A (en) | Use of a first house dust mite group 2 allergen for treating allergy to a second house dust mite group 2 allergen. | |
ATE551036T1 (en) | CONDOM PACKAGING | |
HK1131156A1 (en) | Novel morphine derivatives | |
TNSN08242A1 (en) | 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof | |
MX2012007097A (en) | Phenol derivatives and the pharmaceutical or cosmetic use thereof. | |
MX2011011180A (en) | Compounds having a physiological effect. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |